Microbix Synthetic Vaginal Matrix Matches Donor Samples in HPV Assay Testing

PUBT · 1d ago
Microbix Synthetic Vaginal Matrix Matches Donor Samples in HPV Assay Testing
  • Microbix Biosystems developed a renewable synthetic vaginal matrix to help laboratories validate HPV testing for cervical cancer screening, including self-collected samples.
  • Dry quality controls reconstituted in the matrix detected expected HPV genotypes on an FDA-approved assay, performing comparably to pooled donor samples.
  • Testing showed no signs of assay interference, supporting the matrix's potential use in ongoing quality management.
  • Results will be presented at IPVS 2026 in Athens, Greece, October 22-25, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microbix Biosystems Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202610190700ACCESSWRNAPR_____1237840) on October 19, 2026, and is solely responsible for the information contained therein.